| Dr Stephen John Klinger, MD, MPH | |
|
450 A South Claiborne Ave., Ste. 206, New Orleans, LA 70112 | |
| (614) 937-0319 | |
| Not Available |
| Full Name | Dr Stephen John Klinger |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 19 Years |
| Location | 450 A South Claiborne Ave., Ste. 206, New Orleans, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356531677 | NPI | - | NPPES |
| 1216887 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 200999 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Klinger And Marshall Dermatology, Llc | 0244474625 | 2 |
News Archive
The World Health Organization's new Mental Health Atlas paints a disappointing picture of a worldwide failure to provide people with the mental health services they need, at a time when the COVID-19 pandemic is highlighting a growing need for mental health support.
SignalChem, a global leader in cell signaling and protein engineering, has been conducting research on new coronaviruses since the outbreak of the virus.
SafeMinds sees a brighter future after the implementation of long-overdue EPA regulation of hazardous air pollution from coal-fired power plants. Less mercury means its potent neurotoxic effects are less likely to harm childhood development.
In the daunting marathon that leads to successful drugs, promising drug candidates must pass toxicity tests before entering clinical trials.
A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 8 days ago
| Entity Name | Klinger & Marshall Dermatology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306284591 PECOS PAC ID: 0244474625 Enrollment ID: O20130925000616 |
News Archive
The World Health Organization's new Mental Health Atlas paints a disappointing picture of a worldwide failure to provide people with the mental health services they need, at a time when the COVID-19 pandemic is highlighting a growing need for mental health support.
SignalChem, a global leader in cell signaling and protein engineering, has been conducting research on new coronaviruses since the outbreak of the virus.
SafeMinds sees a brighter future after the implementation of long-overdue EPA regulation of hazardous air pollution from coal-fired power plants. Less mercury means its potent neurotoxic effects are less likely to harm childhood development.
In the daunting marathon that leads to successful drugs, promising drug candidates must pass toxicity tests before entering clinical trials.
A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen John Klinger, MD, MPH 1107 South Peters Street, Unit 404, New Orleans, LA 70130 Ph: () - | Dr Stephen John Klinger, MD, MPH 450 A South Claiborne Ave., Ste. 206, New Orleans, LA 70112 Ph: (614) 937-0319 |
News Archive
The World Health Organization's new Mental Health Atlas paints a disappointing picture of a worldwide failure to provide people with the mental health services they need, at a time when the COVID-19 pandemic is highlighting a growing need for mental health support.
SignalChem, a global leader in cell signaling and protein engineering, has been conducting research on new coronaviruses since the outbreak of the virus.
SafeMinds sees a brighter future after the implementation of long-overdue EPA regulation of hazardous air pollution from coal-fired power plants. Less mercury means its potent neurotoxic effects are less likely to harm childhood development.
In the daunting marathon that leads to successful drugs, promising drug candidates must pass toxicity tests before entering clinical trials.
A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 8 days ago
Suneeta Singh Walia, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Dr. Edward F Pitard, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 602 Robert E Lee Blvd, New Orleans, LA 70124 Phone: 504-888-4040 Fax: 504-888-5959 | |
Dr. Patricia R Hickham, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4141 Bienville St Ste 108, New Orleans, LA 70119 Phone: 504-962-7771 Fax: 504-962-7776 | |
Dr. Deirdre Hooper, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3525 Prytania St, Suite 501, New Orleans, LA 70115 Phone: 504-895-3376 Fax: 504-910-3350 | |
Caroline Elizabeth Lee, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 433 Bolivar St, New Orleans, LA 70112 Phone: 504-568-5600 | |
George Garib, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3330 | |
Dr. Eric M Finley, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2820 Napoleon Ave, Ste 645, New Orleans, LA 70115 Phone: 504-896-2255 Fax: 504-896-2283 |